 | • レポートコード：GIR201114234 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：サービス・ソフトウェア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、薬物安全性・ファーマコビジランスソリューションの世界市場を調査対象にし、薬物安全性・ファーマコビジランスソリューションの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（問題追跡ソリューション、完全統合ソリューション、有害事象報告ソリューション、薬物安全性監査ソフトウェア）、用途別分析（BPO、CRO、製薬会社、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Ennov、Sparta Systems、Extedo、AB-Cube、RxLogix、Oracle、TARA (MedGenesis)、Sarjen Systems、ArisGlobal、United BioSource LLC (UBC)、BaseCon、Indegene ・企業別売上、市場シェア ・薬物安全性・ファーマコビジランスソリューションの地域別市場分析 ・薬物安全性・ファーマコビジランスソリューションの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・薬物安全性・ファーマコビジランスソリューションのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・薬物安全性・ファーマコビジランスソリューションのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・薬物安全性・ファーマコビジランスソリューションの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・薬物安全性・ファーマコビジランスソリューションの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・薬物安全性・ファーマコビジランスソリューションの種類別市場規模2015-2020：問題追跡ソリューション、完全統合ソリューション、有害事象報告ソリューション、薬物安全性監査ソフトウェア ・薬物安全性・ファーマコビジランスソリューションの用途別市場規模2015-2020：BPO、CRO、製薬会社、その他 ・薬物安全性・ファーマコビジランスソリューションの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The Drug Safety and Pharmacovigilance Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Drug Safety and Pharmacovigilance Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Drug Safety and Pharmacovigilance Solution market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Drug Safety and Pharmacovigilance Solution market has been segmented into:
Issue Tracking Solution
Fully Integrated Solution
Adverse Event Reporting Solution
Drug Safety Audits Software
By Application, Drug Safety and Pharmacovigilance Solution has been segmented into:
BPOs
CROs
Pharmaceutical Companies
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drug Safety and Pharmacovigilance Solution market presented in the report. This section sheds light on the sales growth of different regional and country-level Drug Safety and Pharmacovigilance Solution markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drug Safety and Pharmacovigilance Solution market.
The report offers in-depth assessment of the growth and other aspects of the Drug Safety and Pharmacovigilance Solution market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Drug Safety and Pharmacovigilance Solution Market Share Analysis
Drug Safety and Pharmacovigilance Solution competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drug Safety and Pharmacovigilance Solution sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drug Safety and Pharmacovigilance Solution sales, revenue and market share for each player covered in this report.
The major players covered in Drug Safety and Pharmacovigilance Solution are:
Ennov
Sparta Systems
Extedo
AB-Cube
RxLogix
Oracle
TARA (MedGenesis)
Sarjen Systems
ArisGlobal
United BioSource LLC (UBC)
BaseCon
Indegene
Among other players domestic and global, Drug Safety and Pharmacovigilance Solution market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Drug Safety and Pharmacovigilance Solution Market Overview
1.1 Product Overview and Scope of Drug Safety and Pharmacovigilance Solution
1.2 Classification of Drug Safety and Pharmacovigilance Solution by Type
1.2.1 Global Drug Safety and Pharmacovigilance Solution Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Drug Safety and Pharmacovigilance Solution Revenue Market Share by Type in 2019
1.2.3 Issue Tracking Solution
1.2.4 Fully Integrated Solution
1.2.5 Adverse Event Reporting Solution
1.2.6 Drug Safety Audits Software
1.3 Global Drug Safety and Pharmacovigilance Solution Market by Application
1.3.1 Overview: Global Drug Safety and Pharmacovigilance Solution Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 BPOs
1.3.3 CROs
1.3.4 Pharmaceutical Companies
1.3.5 Others
1.4 Global Drug Safety and Pharmacovigilance Solution Market by Regions
1.4.1 Global Drug Safety and Pharmacovigilance Solution Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Drug Safety and Pharmacovigilance Solution (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Drug Safety and Pharmacovigilance Solution Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Drug Safety and Pharmacovigilance Solution Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drug Safety and Pharmacovigilance Solution Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Drug Safety and Pharmacovigilance Solution Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drug Safety and Pharmacovigilance Solution Status and Prospect (2015-2025)
2 Company Profiles
2.1 Ennov
2.1.1 Ennov Details
2.1.2 Ennov Major Business
2.1.3 Ennov SWOT Analysis
2.1.4 Ennov Product and Services
2.1.5 Ennov Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sparta Systems
2.2.1 Sparta Systems Details
2.2.2 Sparta Systems Major Business
2.2.3 Sparta Systems SWOT Analysis
2.2.4 Sparta Systems Product and Services
2.2.5 Sparta Systems Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
2.3 Extedo
2.3.1 Extedo Details
2.3.2 Extedo Major Business
2.3.3 Extedo SWOT Analysis
2.3.4 Extedo Product and Services
2.3.5 Extedo Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
2.4 AB-Cube
2.4.1 AB-Cube Details
2.4.2 AB-Cube Major Business
2.4.3 AB-Cube SWOT Analysis
2.4.4 AB-Cube Product and Services
2.4.5 AB-Cube Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
2.5 RxLogix
2.5.1 RxLogix Details
2.5.2 RxLogix Major Business
2.5.3 RxLogix SWOT Analysis
2.5.4 RxLogix Product and Services
2.5.5 RxLogix Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
2.6 Oracle
2.6.1 Oracle Details
2.6.2 Oracle Major Business
2.6.3 Oracle Product and Services
2.6.4 Oracle Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
2.7 TARA (MedGenesis)
2.7.1 TARA (MedGenesis) Details
2.7.2 TARA (MedGenesis) Major Business
2.7.3 TARA (MedGenesis) Product and Services
2.7.4 TARA (MedGenesis) Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sarjen Systems
2.8.1 Sarjen Systems Details
2.8.2 Sarjen Systems Major Business
2.8.3 Sarjen Systems Product and Services
2.8.4 Sarjen Systems Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
2.9 ArisGlobal
2.9.1 ArisGlobal Details
2.9.2 ArisGlobal Major Business
2.9.3 ArisGlobal Product and Services
2.9.4 ArisGlobal Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
2.10 United BioSource LLC (UBC)
2.10.1 United BioSource LLC (UBC) Details
2.10.2 United BioSource LLC (UBC) Major Business
2.10.3 United BioSource LLC (UBC) Product and Services
2.10.4 United BioSource LLC (UBC) Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
2.11 BaseCon
2.11.1 BaseCon Details
2.11.2 BaseCon Major Business
2.11.3 BaseCon Product and Services
2.11.4 BaseCon Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
2.12 Indegene
2.12.1 Indegene Details
2.12.2 Indegene Major Business
2.12.3 Indegene Product and Services
2.12.4 Indegene Drug Safety and Pharmacovigilance Solution Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Drug Safety and Pharmacovigilance Solution Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Drug Safety and Pharmacovigilance Solution Players Market Share
3.2.2 Top 10 Drug Safety and Pharmacovigilance Solution Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Drug Safety and Pharmacovigilance Solution Revenue and Market Share by Regions
4.2 North America Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
4.3 Europe Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
4.5 South America Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
5 North America Drug Safety and Pharmacovigilance Solution Revenue by Countries
5.1 North America Drug Safety and Pharmacovigilance Solution Revenue by Countries (2015-2020)
5.2 USA Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
5.3 Canada Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
5.4 Mexico Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
6 Europe Drug Safety and Pharmacovigilance Solution Revenue by Countries
6.1 Europe Drug Safety and Pharmacovigilance Solution Revenue by Countries (2015-2020)
6.2 Germany Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
6.3 UK Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
6.4 France Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
6.5 Russia Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
6.6 Italy Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Drug Safety and Pharmacovigilance Solution Revenue by Countries
7.1 Asia-Pacific Drug Safety and Pharmacovigilance Solution Revenue by Countries (2015-2020)
7.2 China Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
7.3 Japan Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
7.4 Korea Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
7.5 India Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
8 South America Drug Safety and Pharmacovigilance Solution Revenue by Countries
8.1 South America Drug Safety and Pharmacovigilance Solution Revenue by Countries (2015-2020)
8.2 Brazil Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
8.3 Argentina Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Drug Safety and Pharmacovigilance Solution by Countries
9.1 Middle East & Africa Drug Safety and Pharmacovigilance Solution Revenue by Countries (2015-2020)
9.2 Saudi Arabia Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
9.3 UAE Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
9.4 Egypt Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
9.5 South Africa Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Drug Safety and Pharmacovigilance Solution Revenue and Market Share by Type (2015-2020)
10.2 Global Drug Safety and Pharmacovigilance Solution Market Forecast by Type (2019-2024)
10.3 Issue Tracking Solution Revenue Growth Rate (2015-2025)
10.4 Fully Integrated Solution Revenue Growth Rate (2015-2025)
10.5 Adverse Event Reporting Solution Revenue Growth Rate (2015-2025)
10.6 Drug Safety Audits Software Revenue Growth Rate (2015-2025)
11 Global Drug Safety and Pharmacovigilance Solution Market Segment by Application
11.1 Global Drug Safety and Pharmacovigilance Solution Revenue Market Share by Application (2015-2020)
11.2 Drug Safety and Pharmacovigilance Solution Market Forecast by Application (2019-2024)
11.3 BPOs Revenue Growth (2015-2020)
11.4 CROs Revenue Growth (2015-2020)
11.5 Pharmaceutical Companies Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Drug Safety and Pharmacovigilance Solution Market Size Forecast (2021-2025)
12.1 Global Drug Safety and Pharmacovigilance Solution Market Size Forecast (2021-2025)
12.2 Global Drug Safety and Pharmacovigilance Solution Market Forecast by Regions (2021-2025)
12.3 North America Drug Safety and Pharmacovigilance Solution Revenue Market Forecast (2021-2025)
12.4 Europe Drug Safety and Pharmacovigilance Solution Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Drug Safety and Pharmacovigilance Solution Revenue Market Forecast (2021-2025)
12.6 South America Drug Safety and Pharmacovigilance Solution Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Drug Safety and Pharmacovigilance Solution Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Drug Safety and Pharmacovigilance Solution Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drug Safety and Pharmacovigilance Solution by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drug Safety and Pharmacovigilance Solution Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Drug Safety and Pharmacovigilance Solution Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Drug Safety and Pharmacovigilance Solution Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Ennov Corporate Information, Location and Competitors
Table 7. Ennov Drug Safety and Pharmacovigilance Solution Major Business
Table 8. Ennov Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2017-2018)
Table 9. Ennov SWOT Analysis
Table 10. Ennov Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 11. Ennov Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Sparta Systems Corporate Information, Location and Competitors
Table 13. Sparta Systems Drug Safety and Pharmacovigilance Solution Major Business
Table 14. Sparta Systems Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2018-2019)
Table 15. Sparta Systems SWOT Analysis
Table 16. Sparta Systems Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 17. Sparta Systems Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Extedo Corporate Information, Location and Competitors
Table 19. Extedo Drug Safety and Pharmacovigilance Solution Major Business
Table 20. Extedo Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2017-2018)
Table 21. Extedo SWOT Analysis
Table 22. Extedo Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 23. Extedo Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. AB-Cube Corporate Information, Location and Competitors
Table 25. AB-Cube Drug Safety and Pharmacovigilance Solution Major Business
Table 26. AB-Cube Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2017-2018)
Table 27. AB-Cube SWOT Analysis
Table 28. AB-Cube Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 29. AB-Cube Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. RxLogix Corporate Information, Location and Competitors
Table 31. RxLogix Drug Safety and Pharmacovigilance Solution Major Business
Table 32. RxLogix Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2017-2018)
Table 33. RxLogix SWOT Analysis
Table 34. RxLogix Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 35. RxLogix Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Oracle Corporate Information, Location and Competitors
Table 37. Oracle Drug Safety and Pharmacovigilance Solution Major Business
Table 38. Oracle Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2017-2018)
Table 39. Oracle SWOT Analysis
Table 40. Oracle Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 41. Oracle Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. TARA (MedGenesis) Corporate Information, Location and Competitors
Table 43. TARA (MedGenesis) Drug Safety and Pharmacovigilance Solution Major Business
Table 44. TARA (MedGenesis) Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2017-2018)
Table 45. TARA (MedGenesis) SWOT Analysis
Table 46. TARA (MedGenesis) Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 47. TARA (MedGenesis) Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Sarjen Systems Corporate Information, Location and Competitors
Table 49. Sarjen Systems Drug Safety and Pharmacovigilance Solution Major Business
Table 50. Sarjen Systems Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2017-2018)
Table 51. Sarjen Systems SWOT Analysis
Table 52. Sarjen Systems Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 53. Sarjen Systems Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. ArisGlobal Corporate Information, Location and Competitors
Table 55. ArisGlobal Drug Safety and Pharmacovigilance Solution Major Business
Table 56. ArisGlobal Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2017-2018)
Table 57. ArisGlobal SWOT Analysis
Table 58. ArisGlobal Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 59. ArisGlobal Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. United BioSource LLC (UBC) Corporate Information, Location and Competitors
Table 61. United BioSource LLC (UBC) Drug Safety and Pharmacovigilance Solution Major Business
Table 62. United BioSource LLC (UBC) Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2017-2018)
Table 63. United BioSource LLC (UBC) SWOT Analysis
Table 64. United BioSource LLC (UBC) Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 65. United BioSource LLC (UBC) Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. BaseCon Corporate Information, Location and Competitors
Table 67. BaseCon Drug Safety and Pharmacovigilance Solution Major Business
Table 68. BaseCon Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2017-2018)
Table 69. BaseCon SWOT Analysis
Table 70. BaseCon Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 71. BaseCon Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Indegene Corporate Information, Location and Competitors
Table 73. Indegene Drug Safety and Pharmacovigilance Solution Major Business
Table 74. Indegene Drug Safety and Pharmacovigilance Solution Total Revenue (USD Million) (2017-2018)
Table 75. Indegene SWOT Analysis
Table 76. Indegene Drug Safety and Pharmacovigilance Solution Product and Solutions
Table 77. Indegene Drug Safety and Pharmacovigilance Solution Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Drug Safety and Pharmacovigilance Solution Revenue (Million USD) by Players (2015-2020)
Table 79. Global Drug Safety and Pharmacovigilance Solution Revenue Share by Players (2015-2020)
Table 80. Global Drug Safety and Pharmacovigilance Solution Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Drug Safety and Pharmacovigilance Solution Revenue Market Share by Regions (2015-2020)
Table 82. North America Drug Safety and Pharmacovigilance Solution Revenue by Countries (2015-2020)
Table 83. North America Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries (2015-2020)
Table 84. Europe Drug Safety and Pharmacovigilance Solution Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Drug Safety and Pharmacovigilance Solution Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Drug Safety and Pharmacovigilance Solution Revenue by Countries (2015-2020)
Table 87. South America Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Drug Safety and Pharmacovigilance Solution Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries (2015-2020)
Table 90. Global Drug Safety and Pharmacovigilance Solution Revenue (Million USD) by Type (2015-2020)
Table 91. Global Drug Safety and Pharmacovigilance Solution Revenue Share by Type (2015-2020)
Table 92. Global Drug Safety and Pharmacovigilance Solution Revenue Forecast by Type (2021-2025)
Table 93. Global Drug Safety and Pharmacovigilance Solution Revenue by Application (2015-2020)
Table 94. Global Drug Safety and Pharmacovigilance Solution Revenue Share by Application (2015-2020)
Table 95. Global Drug Safety and Pharmacovigilance Solution Revenue Forecast by Application (2021-2025)
Table 96. Global Drug Safety and Pharmacovigilance Solution Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Drug Safety and Pharmacovigilance Solution Picture
Figure 2. Global Drug Safety and Pharmacovigilance Solution Revenue Market Share by Type in 2019
Figure 3. Issue Tracking Solution Picture
Figure 4. Fully Integrated Solution Picture
Figure 5. Adverse Event Reporting Solution Picture
Figure 6. Drug Safety Audits Software Picture
Figure 7. Drug Safety and Pharmacovigilance Solution Revenue Market Share by Application in 2019
Figure 8. BPOs Picture
Figure 9. CROs Picture
Figure 10. Pharmaceutical Companies Picture
Figure 11. Others Picture
Figure 12. Global Drug Safety and Pharmacovigilance Solution Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Drug Safety and Pharmacovigilance Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Drug Safety and Pharmacovigilance Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Drug Safety and Pharmacovigilance Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Drug Safety and Pharmacovigilance Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Drug Safety and Pharmacovigilance Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Drug Safety and Pharmacovigilance Solution Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Drug Safety and Pharmacovigilance Solution Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Drug Safety and Pharmacovigilance Solution Revenue Market Share in 2019
Figure 21. Global Top 10 Players Drug Safety and Pharmacovigilance Solution Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Drug Safety and Pharmacovigilance Solution Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Drug Safety and Pharmacovigilance Solution Revenue Market Share by Regions (2015-2020)
Figure 25. Global Drug Safety and Pharmacovigilance Solution Revenue Market Share by Regions in 2018
Figure 26. North America Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 27. Europe Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 29. South America Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 31. North America Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries (2015-2020)
Figure 32. North America Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries in 2019
Figure 33. USA Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 34. Canada Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 36. Europe Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries in 2019
Figure 38. Germany Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 39. UK Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 40. France Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 41. Russia Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 42. Italy Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries in 2019
Figure 45. China Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 46. Japan Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 47. Korea Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 48. India Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 50. South America Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries (2015-2020)
Figure 51. South America Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries in 2019
Figure 52. Brazil Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Drug Safety and Pharmacovigilance Solution Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 57. UAE Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Drug Safety and Pharmacovigilance Solution Revenue and Growth Rate (2015-2020)
Figure 60. Global Drug Safety and Pharmacovigilance Solution Revenue Share by Type (2015-2020)
Figure 61. Global Drug Safety and Pharmacovigilance Solution Revenue Share by Type in 2019
Figure 62. Global Drug Safety and Pharmacovigilance Solution Market Share Forecast by Type (2021-2025)
Figure 63. Global Issue Tracking Solution Revenue Growth Rate (2015-2020)
Figure 64. Global Fully Integrated Solution Revenue Growth Rate (2015-2020)
Figure 65. Global Adverse Event Reporting Solution Revenue Growth Rate (2015-2020)
Figure 66. Global Drug Safety Audits Software Revenue Growth Rate (2015-2020)
Figure 67. Global Drug Safety and Pharmacovigilance Solution Revenue Share by Application (2015-2020)
Figure 68. Global Drug Safety and Pharmacovigilance Solution Revenue Share by Application in 2019
Figure 69. Global Drug Safety and Pharmacovigilance Solution Market Share Forecast by Application (2021-2025)
Figure 70. Global BPOs Revenue Growth Rate (2015-2020)
Figure 71. Global CROs Revenue Growth Rate (2015-2020)
Figure 72. Global Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Drug Safety and Pharmacovigilance Solution Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Drug Safety and Pharmacovigilance Solution Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Drug Safety and Pharmacovigilance Solution Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Drug Safety and Pharmacovigilance Solution Revenue Market Forecast (2021-2025)
Figure 78. Europe Drug Safety and Pharmacovigilance Solution Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Drug Safety and Pharmacovigilance Solution Revenue Market Forecast (2021-2025)
Figure 80. South America Drug Safety and Pharmacovigilance Solution Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Drug Safety and Pharmacovigilance Solution Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
医薬品安全性ソリューション・ファーマコビジランスの世界市場 2020年 Market Overview The global Drug Safety Solutions and Pharmacovigilance market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The D…- ファーマコビジランス（PV）アウトソーシングの世界市場 2020年 Market Overview The global Pharmacovigilance (PV) Outsourcing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pharmacovi…
- 運用保守監査ソリューションの世界市場 2020年 Market Overview The global Operation & Maintenance Audit Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Operat…
- レンタカー管理ソリューションの世界市場 2020年 Market Overview The global Car Rental Management Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Car Rental Man…
- モバイルアプリケーションテストソリューションの世界市場 2020年 Market Overview The global Mobile Application Testing Solution market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.3% in the forecast period of 2020 to 2025 and will expected to reach USD 3946.3 million by 2025, from USD 2864.4 million in 2019. The …